As a typical immunosuppressive tryptophan metabolite, a higher kynurenine/tryptophan ratio has been found to be associated with a poor response to anti-PD-1 in NSCLC patients50. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.